AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit

Histone hypoacetylation occurs in many cancers and inhibition of histone deacetylation is a promising approach to modulate these epigenetic changes. Our laboratory previously demonstrated that the histone deacetylase inhibitors (HDACis) vorinostat and AR-42 reduced the viability of a canine malignan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lin, Tzu-Yin, Fenger, Joelle, Murahari, Sridhar, Bear, Misty D., Kulp, Samuel K., Wang, Dasheng, Chen, Ching-Shih, Kisseberth, William C., London, Cheryl A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2010
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3398750/
https://ncbi.nlm.nih.gov/pubmed/20233974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-07-231985
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados